ACTRN12619000469112进行中（未招募）未知
Systems performance and glucose control using an advanced hybrid closed-loop system in type 1 diabetes: Insulin aspart vs. faster acting insulin aspart (FiASP)
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Type 1 diabetes of >1 year duration
- •Stable on insulin pump therapy for >3 months
- •Proficient in carbohydrate counting
- •Continuous glucose monitoring (CGM) sensor experience
- •HbA1c <10.0%
排除标准
- •eGFR <40ml/min/1.73m2
- •History of diabetic ketoacidosis or severe hypoglycaemia in the last 3 months
- •Diabetic gastroparesis
研究者
相似试验
尚未招募
不适用
Faster insulin aspart (FiASP) vs. apart using an advanced closed-loop system: Extension study evaluating meal-time glucose controltype 1 diabetesACTRN12619001340123Medtronic Diabetes12
已完成
不适用
The effect of blood glucose control by artificial endocrine pancreas on oxidative stress and postoperative AKIJPRN-UMIN000019725Tokushima University Hospital40
已完成
不适用
The effect of blood glucose control by artificial endocrine pancreas in patients undergoing cardiac surgery on postoperative AKIacute kidney injuryJPRN-UMIN000019691Tokushima University Hospital30
尚未招募
Unknown
EVOLUTION trial (EValuating glucose contrOL Using a next generaTION automated insulin delivery algorithm in patients with type 1 and type 2 diabetes: EVOLUTION): Phase 4Type 1 diabetes mellitusACTRN12623000634673niversity of Otago24
已完成
Unknown
EVOLUTION trial (EValuating glucose contrOL Using a next generaTION automated insulin delivery algorithm in patients with type 1 and type 2 diabetes: EVOLUTION)Type 2 diabetes mellitusMetabolic and Endocrine - DiabetesType 1 diabetes mellitusACTRN12623000623695niversity of Otago20